Oxford Medical

Oxford Medical Products (OMP) is a UK-based biotechnology company specializing in non-pharmacological and drug-delivery solutions for obesity and metabolic health. The company's flagship product, Sirona, is an oral, once-daily hydrogel pill that expands in the stomach to mechanically induce satiety, effectively mimicking the mechanism of a gastric balloon without the need for surgery. OMP is also leveraging its proprietary gastroretentive hydrogel platform (OMP GEL) to develop controlled-release delivery systems for small molecules and biologics, aiming to improve oral bioavailability and patient adherence. With positive first-in-human safety data, the company is advancing toward pivotal trials to provide a scalable, cost-effective alternative or adjunct to GLP-1 therapies.